Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study

Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study

This study aimed to evaluate the antibody and cellular responses to different coronavirus 2019 (COVID-19) vaccination regimens in patients with cirrhosis and to assess the antibody response after a vaccine booster. We conducted a prospective observational study of 89 patients with cirrhosis and 41 h...

Full description

Bibliographic Details
Main Authors: Pimsiri Sripongpun, Nawamin Pinpathomrat, Ratchanon Sophonmanee, Jomkwan Ongarj, Purilap Seepathomnarong, Bunya Seeyankem, Naichaya Chamroonkul, Teerha Piratvisuth, Apichat Kaewdech
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Vaccines
Subjects:
booster
cirrhosis
immune response
SARS-CoV-2
vaccination
Online Access:https://www.mdpi.com/2076-393X/11/9/1455

Internet

https://www.mdpi.com/2076-393X/11/9/1455

Similar Items